Purpose En bloc resection of bladder tumors (ERBT) may improve staging quality and
perioperative morbidity and influence tumor recurrence. This study was designed to evaluate the …

A quantitative imaging biomarker is desirable to provide a comprehensive measure of whole-body
tumor burden in patients with metastatic prostate cancer, and to standardize the …

Background The degree of antitumour activity of enzalutamide following disease progression
on docetaxel and abiraterone remains controversial. Objective To examine the effect of …

Purpose The aim of this study was to assess the value of dual-time point imaging in PET/CT
for detection of biochemically recurrent or persistent prostate cancer, using the prostate-…

Purpose The goal of this work was to evaluate the early efficacy of 68Ga-PSMA ligand PET/CT
imaging for radiotherapy of locally recurrent and/or oligometastatic prostate cancer. …

Purpose To determine the patterns of progression after 68 Ga prostate-specific membrane
antigen (PSMA)-ligand positron emission tomography (PET)/computed tomography (CT)-…

Enzalutamide is an oral androgen receptor inhibitor that targets multiple steps in the
androgen receptor signaling pathway. In the randomized phase III AFFIRM study, significant …

Purpose The aims of this study were to gain mechanistic insights into prostate cancer
biology using dynamic imaging and to evaluate the usefulness of multiple time-point 68 Ga–…

Androgen deprivation therapy (ADT) is well established as a backbone therapy for metastatic
prostate cancer (mPCa), and both European and American guidelines emphasize the …

Purpose [ 68 Ga]Tris(hydroxypyridinone)(THP)-PSMA is a novel radiopharmaceutical for
one-step kit-based radiolabelling, based on direct chelation of 68 Ga 3+ at low concentration, …